Inventor · disambiguated record
James T. Palmer
Also filed as: PALMER JAMES · PALMER JAMES T
36 granted patents·25 pending applications·589 citations·filing 1990–2025
97Inventor score
Files withBIOMEA FUSION INC16AXYS PHARM INC14JANKOWSKI ORION D4Cardio Therapeutics Pty Ltd3PROTOTEK INC3
Top patents by PatentIndex Score
61 records- 0195US6506733B1Compounds and compositions as protease inhibitorsAXYS PHARM INC·Filed 2000·Granted Jan 14, 2003·40 cites·18 claims
- 0294US8461161B2Substituted pyrazines as inhibitors of kinase activityBURNS CHRISTOPHER JOHN·Filed 2007·Granted Jun 11, 2013·46 cites·11 claims
- 0394US5776718AReversible protease inhibitorsARRIS PHARM CORP·Filed 1996·Granted Jul 7, 1998·95 cites·53 claims
- 0492US8067395B2Inhibitors of tyrosine kinases and uses thereofJANKOWSKI ORION D·Filed 2009·Granted Nov 29, 2011·17 cites·20 claims
- 0591US6287840B1Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groupsAXYS PHARM INC·Filed 1999·Granted Sep 11, 2001·49 cites·32 claims
- 0689US7973037B2Cathepsin cysteine protease inhibitorsAXYS PHARM INC·Filed 2008·Granted Jul 5, 2011·12 cites·10 claims
- 0789US7625880B2Inhibitors of tyrosine kinases and uses thereofPHARMACYCLICS INC·Filed 2006·Granted Dec 1, 2009·9 cites·20 claims
- 0888US7012075B2Cathepsin cysteine protease inhibitorsAXYS PHARM INC·Filed 2002·Granted Mar 14, 2006·52 cites·29 claims
- 0988US6476026B1Compounds and compositions as protease inhibitorsAXYS PHARM INC·Filed 2000·Granted Nov 5, 2002·27 cites·13 claims
- 1086US9029386B2Pyridine derivatives useful as kinase inhibitorsYM BIOSCIENCES AUSTRALIA PTY·Filed 2013·Granted May 12, 2015·10 cites·16 claims
- 1186US6030946AReversible cysteine protease inhibitorsAXYS PHARM INC·Filed 1996·Granted Feb 29, 2000·78 cites·21 claims
- 1286US5976858AIrreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groupsARRIS PHARMACEUTICALS·Filed 1995·Granted Nov 2, 1999·73 cites·9 claims
- 1381US6593327B2Compounds and compositions as protease inhibitorsAXYS PHARM INC·Filed 2001·Granted Jul 15, 2003·11 cites·13 claims
- 1479US8772336B2Cathepsin cysteine protease inhibitorsMERCK FROSST CANADA INC·Filed 2012·Granted Jul 8, 2014·3 cites·14 claims
- 1575US5210272AProcess for forming a fluoromethyl ketonePROTOTEK INC·Filed 1991·Granted May 11, 1993·14 cites·5 claims
- 1673US12215113B2Crystalline forms of N[4[4-(4-Morpholinyl)-7H-Pyrrolo[2-3-D]Pyrimidin-6-yl]Phenyl]-4-[[3(R)-[(1-Oxo-2-Protein-1-yl)Amino]-1-Piperidinyl]Methyl]2-Pyridinecarboxamide]BIOMEA FUSION INC·Filed 2024·Granted Feb 4, 2025·0 cites·35 claims
- 1773US7196099B2Compounds and compositions as cathepsin inhibitorsAXYS PHARM INC·Filed 2004·Granted Mar 27, 2007·6 cites·13 claims
- 1873US2025161320A1Covalent inhibitors of menin-mll interaction for diabetes mellitusBIOMEA FUSION INC·Filed 2024·Application pending·0 cites
- 1973US2024262795A1Pyrazine compounds as inhibitors of flt3BIOMEA FUSION INC·Filed 2024·Application pending·0 cites
- 2072US8318748B2Cathepsin cysteine protease inhibitorsBAYLY CHRISTOPHER I·Filed 2011·Granted Nov 27, 2012·2 cites·18 claims
- 2171US11945785B2Pyrazine compounds as inhibitors of FLT3BIOMEA FUSION INC·Filed 2022·Granted Apr 2, 2024·0 cites·28 claims
- 2271US8906902B2Antibacterial compoundsBIOTA EUROPE LTD·Filed 2013·Granted Dec 9, 2014·2 cites·22 claims
- 2369US12251385B2Covalent inhibitors of menin-MLL interaction for diabetes mellitusBIOMEA FUSION INC·Filed 2022·Granted Mar 18, 2025·0 cites·17 claims
- 2469US12018032B2Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide as an irreversible inhibitor of menin-MLL interactionBIOMEA FUSION INC·Filed 2022·Granted Jun 25, 2024·0 cites·19 claims
- 2569US2024417404A1CRYSTALLINE FORMS OF N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO-2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINECARBOXAMIDE AS IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTIONBIOMEA FUSION INC·Filed 2024·Application pending·0 cites
- 2668US9181234B2Antibacterial compoundsPALMER JAMES T·Filed 2011·Granted Nov 10, 2015·3 cites·17 claims
- 2767US5328506APigment products in an agglomerated form and use thereof in bulk shipmentsENGELHARD CORP·Filed 1992·Granted Jul 12, 1994·23 cites·21 claims
- 2866US5101068AMagnesium fluoromalonatesPROTOTEK INC·Filed 1990·Granted Mar 31, 1992·7 cites·7 claims
- 2962US7030116B2Compounds and compositions as cathepsin inhibitorsAXYS PHARM INC·Filed 2002·Granted Apr 18, 2006·1 cites·9 claims
- 3062US2014256743A1Cathepsin cysteine protease inhibitorsMERCK FROSST CANADA LTD·Filed 2014·Application pending·0 cites
- 3162US2025312335A1Flt combination therapy for cancer and compositions thereforBIOMEA FUSION INC·Filed 2023·Application pending·0 cites
- 3262US2025353854A1Fused pyrimidine compounds as inhibitors of meninBIOMEA FUSION INC·Filed 2023·Application pending·0 cites
- 3361US2024343731A1Crystalline forms of an irreversible inhibitor of menin-mll interactionBIOMEA FUSION INC·Filed 2024·Application pending·0 cites
- 3460US11897868B2Heterocyclic inhibitors of PCSK9Cardio Therapeutics Pty Ltd·Filed 2021·Granted Feb 13, 2024·0 cites·17 claims
- 3560US2024409558A1Irreversible inhibitors of krasBIOMEA FUSION INC·Filed 2022·Application pending·0 cites
- 3659US5344939AProcess for forming a fluoromethyl ketonePROTOTEK INC·Filed 1993·Granted Sep 6, 1994·5 cites·4 claims
- 3759US2025066386A1Inhibitors of krasBIOMEA FUSION INC·Filed 2022·Application pending·0 cites
- 3859US2025304572A1Heterocyclic glp-1r agonistsBIOMEA FUSION INC·Filed 2025·Application pending·0 cites
- 3958US2025136558A1Pyrazine compounds as irreversible inhibitors of flt3BIOMEA FUSION INC·Filed 2022·Application pending·0 cites
- 4057US2024124467A1Fused pyrimidine compounds as inhibitors of menin-mll interactionBIOMEA FUSION INC·Filed 2021·Application pending·0 cites
- 4157US2012108547A1Inhibitors of tyrosine kinases and uses thereofJANKOWSKI ORION D·Filed 2011·Application pending·0 cites
- 4257US2025243207A1Synthetic methods for preparing a pyridinecarboxamide compoundBIOMEA FUSION INC·Filed 2022·Application pending·0 cites
- 4357US2012101065A1Inhibitors of tyrosine kinases and uses thereofJANKOWSKI ORION D·Filed 2011·Application pending·0 cites
- 4456US2012083470A1Inhibitors of tyrosine kinases and uses thereofJANKOWSKI ORION D·Filed 2011·Application pending·0 cites
- 4554US2007135386A1Novel Compounds and Compositions as Cathepsin InhibitorsAXYS PHARM INC·Filed 2007·Application pending·0 cites
- 4653US9121824B2Fluidic and electrical interface for microfluidic chipsPALMER JAMES T·Filed 2012·Granted Sep 1, 2015·1 cites·21 claims
- 4753US2003119788A1Novel compounds and compositions as protease inhibitorsAXYS PHARM INC·Filed 2002·Application pending·0 cites
- 4851US9604976B2Antibacterial compoundsSPERO GYRASE INC·Filed 2013·Granted Mar 28, 2017·0 cites·16 claims
- 4950US5008433A2-hydroxy-3-(4-methoxyphenyl)-3-(2-aminophenylthio)propionic acid, 8'-phenylmenthyl ester, especially for diltiazemMARION LABORATORIES INC·Filed 1990·Granted Apr 16, 1991·3 cites·2 claims
- 5050US2006089357A1Novel compounds and compositions as cathepsin inhibitorsAXYS PHARM INC·Filed 2005·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James T. Palmer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →